Canaan Partners VIII’s Cardlytics CDLX Stock Holding History

Canaan Partners VIII’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-113,314	Closed	-$29.4M	–	3
2019 Q2	$29.4M	Sell	113,314 -48,500	-30%	-$9.71M	58.62%	1
2019 Q1	$26.8M	Sell	161,814 -75,000	-32%	-$12.2M	47.52%	2
2018 Q4	$25.6M	Buy	+236,814	New	+$39.9M	31.6%	2

Other funds holding CDLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Canaan Partners VIII's CDLX Position: Q3 2019 in Review

Canaan Partners VIII sold out of Cardlytics (CDLX) in Q3 2019, closing a stake of 113,314 shares — an estimated $29.4M sold.

Canaan Partners VIII first reported a position in CDLX in Q4 2018 and held it in 3 quarters. The position peaked at $29.4M in Q2 2019. 117 funds tracked by Wall St. Rank hold CDLX as of Q3 2019.

Canaan Partners VIII reported no remaining Cardlytics position as of Q3 2019 after selling out during the quarter.
Canaan Partners VIII sold 113,314 Cardlytics shares in Q3 2019, an estimated $29.4M.
Canaan Partners VIII first reported a position in Cardlytics in Q4 2018 and held it in 3 quarters.
Canaan Partners VIII's Cardlytics position peaked at $29.4M in Q2 2019.
117 funds tracked by Wall St. Rank held Cardlytics as of Q3 2019.

Based on Canaan Partners VIII's 13F filing for Q3 2019, filed 22 Oct 2019.